Pilot Health Phase 1
Forecasted
Pilot Health Phase 1 supports public healthcare bodies and businesses in joint R&D to develop needs-led innovations that strengthen sustainable healthcare and create value in Norwegian industry.
Funder: Research Council of Norway
Due Dates (Anticipated): January 2027 (Application deadline)
Funding Amounts: Up to 80% of approved costs for public agencies; company support stated at 25–70%, depending on size and R&D activity
Summary: Supports needs-led public–private R&D that strengthens sustainable healthcare services and creates value in Norwegian industry.
Key Information: A Norwegian healthcare-sector public body and a business registered and economically active in Norway must collaborate.
Description
Pilot Health, run by the Research Council of Norway, supports innovation processes based on recognised needs of patients, citizens and public healthcare services. Public and private actors jointly develop technologies, processes, products and services that can reach users faster, improve healthcare sustainability and create value in Norwegian industry. Healthcare-service and industry needs must be equally represented.
Projects must combine R&D with credible plans for implementation, commercialisation and scaling in Norwegian and international markets. User involvement should inform needs assessment, development testing and deployment. Priorities are coordination between primary and specialist healthcare, prevention and coping, living at home longer through digital follow-up or home hospitals, and civil and military emergency preparedness. Innovations should enable safe, equal, personalised, high-quality services without increasing burdens on services, society or the environment.
